Further analysis of the activity of the catabolic pathways revealed that TLR4 deficiency prevented tumor-induced activation of p38 MAPK and NF-κB (p65), upregulation of ubiquitin ligases UBR2 and atrogin1, activation of autophagy, and loss of MHC (Fig. 4A). This evidence concerns the gene TLR4 and neoplasm.